Red Bean shares again denied injecting Taxol

Red Bean shares (600400, closing price of 9.04 yuan) last November clarified the issue of Taxol injection. However, as the company's share price continued to rise, the cumulative increase since the new year has nearly 30%, "injected paclitaxel" rumors in the major financial sites of the red Bean shares in the spread.　　In this respect, the daily economic news reporter yesterday (January 18) to call the company, the company said that Taxol injection into the listed companies is simply not possible, and large shareholders do have the yew and general technology two assets listed separately.　　Taxol injection rumors of the company denied the same as other stock, red Bean shares in the recent surge in share prices behind the scenes, or online stocks bar rumors. "Daily economic news" reporter noted that recently in the red bean stock stocks bar, almost every day left this sentence: "The group intends to inject Taxol injection project." At present, the Red Bean group can produce more than 100 kilograms of Taxol, paclitaxel injections have begun to sell, the annual sales of paclitaxel is expected to be about 1.2 billion. "If the rumor is true, it will be a big attraction," he said. Data show that Taxol is ranked the world's first cancer drugs.　　Its extract of Taxol is more expensive than gold, once as high as tens of millions of dollars per kilogram. Ironically, it was only in mid-November last year that the red bean stock had clarified the asset injection. According to the November 17, 2010 announcement, "the company confirmed that there is no intention to acquire Taxol belongs to the Yew Biotechnology Co., Ltd. stock rights." In addition, the next 3 months do not plan major asset restructuring, acquisitions and other acts. However, a broker close to the company revealed to reporters that the group plans to separate the yew and tyre assets on the market separately.　　If the market simply hype the concept of Taxol, it does not really match the fundamentals. Data show that the red Bean Group's business includes 5 pieces, respectively, clothing, yew, real estate, tires and locomotives. Yew Company has officially put into production of Taxol refinery 1, after the production will gradually form 100 kg ~300 kg capacity, more than 5 billion yuan annual sales revenue.　　In addition, 2009, the main tire of Jiangsu General Technology company formed an annual output of 2 million sets of high-performance, environmentally-friendly All-steel radial truck tire production scale. Yesterday, the daily economic news reporter in the identity of investors to call Red Bean shares, the company's securities representative Wang Hui said that major shareholders do have the yew and general technology companies listed separately, the plan is still in preparation. In fact, it is impossible to inject Taxol into a listed company.　　At present, the company's stock price higher, do not rule out some funds deliberately release the news hype.　　The focus of the company's business is still clothing if there is no Taxol concept, then what is the future of red Bean shares worthy of attention? Wang said that although the real estate business contributed to the main income, but the next 2-3 years, the focus of the company's business is still clothing. Especially the channel construction. Because of the red bean stock clothing positioning for the mid-range business leisure, it will focus on expanding the market of three or four-line cities. In addition, the estimated 2010 years the company's apparel business performance smooth.　　In the first half of 2010, the company's clothing business to achieve income of 245 million yuan, an increase of 6.6%, accounting for the main income proportion of 18%, the same period, the real estate business contribution of 942 million yuan, accounting for 69%. "Red Bean Group of unlisted companies also have high-quality underwear assets, the future will not exclude the group into the possibility of the listed companies." A broker said to reporters.